Demographics and Outcomes of Pulmonary Hypertension Patients in United States Emergency Departments by Wilcox, Susan R. et al.
UC Irvine
Western Journal of Emergency Medicine: Integrating Emergency 
Care with Population Health
Title
Demographics and Outcomes of Pulmonary Hypertension Patients in United States 
Emergency Departments
Permalink
https://escholarship.org/uc/item/1192d4rd
Journal
Western Journal of Emergency Medicine: Integrating Emergency Care with Population 
Health, 21(3)
ISSN
1936-900X
Authors
Wilcox, Susan R.
Faridi, M. Kamal
Camargo Jr., Carlos A.
Publication Date
2020
DOI
10.5811/westjem.2020.2.45187
Supplemental Material
https://escholarship.org/uc/item/1192d4rd#supplemental
License
https://creativecommons.org/licenses/by/4.0/ 4.0
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Western Journal of Emergency Medicine 714 Volume 21, no. 3: May 2020
Original research
 
Demographics and Outcomes of Pulmonary Hypertension 
Patients in United States Emergency Departments
 
Susan R. Wilcox, MD
M. Kamal Faridi, MPH
Carlos A. Camargo Jr., MD, DrPH
Section Editor: Gary Johnson, MD         
Submission history: Submitted September 12, 2019; Revision received February 21, 2020; Accepted February 27, 2020 
Electronically published April 16, 2020         
Full text available through open access at http://escholarship.org/uc/uciem_westjem   
DOI: 10.5811/westjem.2020.2.45187 
INTRODUCTION 
Pulmonary hypertension (PH) is defined as pressure 
elevation in the pulmonary circulation with a mean pulmonary 
artery pressure over 25 millimeters of mercury (mmHg)1 and 
can arise from a multitude of physiologic insults resulting in 
increased pulmonary vascular resistance. This sustained elevation 
in pressure leads to strain on the right ventricle2 and eventual 
heart failure if untreated.3 In addition to resulting in chronic 
issues, PH impacts the approach to resuscitation, as common 
interventions such as volume administration or intubation can be 
Massachusetts General Hospital, Department of Emergency Medicine, Boston, 
Massachusetts
Introduction: Pulmonary hypertension (PH) is a common, yet under-diagnosed, contributor to 
morbidity and mortality. Our objective was to characterize the prevalence of PH among adult patients 
presenting to United States (US) emergency departments (ED) and to identify demographic patterns 
and outcomes of PH patients in the ED.
Methods: We analyzed the Nationwide Emergency Department Sample (NEDS) database, with 
a focus on ED patients aged 18 years and older, with any International Classification of Diseases, 
Clinical Modification (ICD)-9-CM or ICD-10-CM diagnosis code for PH from 2011 to 2015. The primary 
outcome was inpatient, all-cause mortality. The secondary outcomes were hospital admission rates 
and hospital length of stay (LOS). 
Results: From 2011 to 2015, in a sample of 121,503,743 ED visits, representing a weighted estimate 
of 545,500,486 US ED visits, patients with a diagnosis of PH accounted for 0.78% (95% confidence 
interval [CI], 0.75- 0.80%) of all US ED visits. Of the PH visits, 86.9% were admitted to the hospital, 
compared to 16.3% for all other ED visits (P <0.001). Likewise, hospital LOS and hospital-based 
mortality were higher in the PH group than for other ED patients (e.g., inpatient mortality 4.5% vs 
2.6%, P < 0.001) with an adjusted odds ratio (aOR) of 1.34 (95% CI, 1.31–1.37). Age had the strongest 
association with mortality, with an aOR of 10.6 for PH patients over 80 years (95% CI, 10.06–11.22), 
compared to a reference of ages 18 to 30 years.
Conclusion: In this nationally representative sample, presentations by patients with PH were relatively 
common, accounting for nearly 0.8% of US ED visits. Patients with PH were significantly more likely 
to be admitted to the hospital than all other patients, had longer hospital LOS, and increased risk of 
inpatient mortality. [West J Emerg Med. 2020;21(3)714–721.]
deleterious in the setting of right heart failure.2,4 
Despite having substantial clinical impact, PH remains 
under-diagnosed.5 Over the last 30 years, clinicians outside the 
emergency department (ED) have increasingly recognized the 
risks of PH and right ventricular failure,2,6 but this diagnosis has 
been underappreciated during emergency care.4,7,8 Quantifying 
the burden of PH in the ED is difficult, as it is a heterogeneous 
condition, with five groups defined by the World Health 
Organization based upon the underlying etiology.9 Data are 
sparse for the rates of patients with PH presenting to EDs, and 
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Population Health Research Capsule
What do we already know about this issue?
Pulmonary hypertension (PH) is an under-
diagnosed condition with high morbidity and 
mortality.
What was the research question?
We analyzed the national database of ED 
visits to assess the inpatient, all-cause 
mortality of PH patients.
What was the major finding of the study?
Patients with a diagnosis of PH accounted 
for 0.78% of all United States ED visits, with 
an adjusted odds ratio for mortality of 1.34.
How does this improve population health?
PH is relatively common among ED visits, 
and is associated with increased rate of 
inpatient mortality.
there are no studies of the diagnosis or management of PH in the 
ED. The only demographic study of all groups of PH in the ED 
was a single-center study, finding a 0.84% prevalence of PH in 
ED visits.10 A large epidemiologic study of ED visits focused on 
Group 1 PH, or pulmonary arterial hypertension (PAH), a rare 
disease with estimates of 5-15 cases per one million adults.11 Yet 
even this rare condition was responsible for approximately 0.01% 
of all ED visits.12 The remaining literature on the assessment 
of PH in the ED is limited to case reports13,14 and a small 
observational study.15 
Improving the care of patients with PH in the ED begins 
with appropriate recognition of the condition. While it may seem 
evident that patients with PH have higher-acuity ED presentations 
as compared to other patients, the magnitude of this discrepancy 
is unknown. Quantifying the prevalence and acuity of patients 
with of PH in the ED is therefore integral to designing future 
studies of the emergency management of PH. 
Our objective was to characterize the prevalence of 
PH among adult patients presenting to the ED, identify 
demographic patterns of these patients, and to evaluate 
admission rates, hospital length of stay (LOS), and inpatient 
mortality for these patients. 
METHODS
We analyzed the Nationwide Emergency Department 
Sample (NEDS) database, developed for the Healthcare Cost 
and Utilization Project (HCUP) sponsored by the Agency for 
Healthcare Research and Quality and constructed annually using 
records from state ED databases and state inpatient databases, 
to collect data on all ED visits, regardless of disposition. NEDS 
is the largest ED database in the US, yielding national estimates 
of hospital-based ED visits, and providing a snapshot of 
demographics for selected conditions. Unweighted, it contains 
data from approximately 30 million ED visits each year. 
Weighted, it estimates roughly 135 million ED visits per year.16 
This study was declared exempt from review by the institutional 
review board of Massachusetts General Hospital.
Patients included for analysis were those ages 18 years and 
older, with any ED visit, with a diagnosis that met the 9th or 10th 
revision of the International Classification of Diseases, Clinical 
Modification (ICD-9-CM or ICD-10-CM, respectively) codes for 
PH, including Groups 1-5 of PH in the first through 10th diagnosis 
field.9 Patients were included if they had a code for PH as an ED 
diagnosis or hospital diagnosis. The list of included ICD-9-CM 
and ICD-10-CM codes are provided in the Supplemental File. 
In the HCUP outpatient databases, the first listed diagnosis is the 
condition considered to be chiefly responsible for the visit.
We collected data from NEDS from 2011–2015, including 
demographic characteristics of age, gender, and national quartile 
for median household income, as estimated by the patient’s home 
ZIP code. Primary insurance types were categorized as public 
(Medicare and Medicaid), private, self-pay, and other. ED visit 
data were reviewed, including diagnoses, ED disposition, and 
hospital disposition. We also reviewed hospital characteristics, 
such as geographic region (Northeast, South, Midwest, and 
West) as defined by the US Census Bureau, and annual ED visit 
volume, trauma center designation, urban or rural status, and 
teaching status. 
The primary outcome measure was inpatient, all-cause 
mortality. The secondary outcomes were hospital admission 
rates and hospital LOS. Of note, data on ED LOS, ED 
observation unit admission, and intensive care unit admission 
are not available in NEDS.
Statistical Analysis 
All analyses included appropriate inflation using sampling 
weights, and we estimated variance using all observations in 
the database to account for domain-level variance. ED visits by 
patients with PH were compared to all ED visits. We reported 
weighted frequencies and proportions with corresponding 95% 
confidence intervals (CI) for patient and hospital characteristics, 
and used chi-square test to test statistical significance. Hospital-
based mortality was computed by dividing the number of ED 
and inpatient, any-cause deaths by the number of PH-related ED 
visits. Because no unique patient identifiers were provided with 
ED records, the unit of analysis for the study was an ED visit. We 
ran bivariate analyses to explore associations of inpatient death, 
total ED visits, ED disposition, and hospital LOS with PH visits. 
We ran a multivariable logistic-regression model to test 
the relationship between PH ED visits and inpatient mortality. 
Our goal was to assess the outcomes attributable to PH, while 
controlling for confounders. We selected variables a priori for 
possible inclusion in the model; the final model was chosen 
using lowest Akaike’s information criterion with the following 
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predictors: age, gender, patient’s primary health insurance, 
geographic location, trauma center status, and teaching status of 
the hospitals. To assess change over time in admission rates and 
inpatient mortality rates for pulmonary hypertension visits, we 
ran logistic regression models with year as a continuous variable. 
All analyses were conducted using SAS version 9.4 (SAS 
Institute, Cary, NC) software. A two-sided P-value of < 0.05 was 
considered statistically significant.
RESULTS
Characteristics of Study Subjects 
From 2011 to 2015, there was a weighted estimate of 
4,233,762 US ED visits, with an annual average of 846,752 
visits among adults with PH, which accounted for 0.78% (95% 
confidence interval [CI], 0.75-0.80%) of all US ED visits 
for adults. Table 1 shows the weighted results. Patients with 
PH were significantly older than the entire ED cohort, with a 
higher percentage of visits for patients 61 years and older, and 
were comprised of more women, at 61.0% compared to 57.3% 
for all ED visits (P < 0.001). PH patients were more likely to 
have public insurance (84.4% vs 49.8%, P < 0.001) and have 
been seen at metropolitan teaching hospitals (53.0% vs 46.3%, 
P < 0.001). A PH code was the primary code for 118,351 
visits, unweighted, for a weighted frequency of 525,904 visits 
(0.096%, 95% CI, 0.092-0.10).
Main Results
Of the weighted 4,233,762 ED visits for patients with a 
diagnosis of PH, 86.9% were admitted to the hospital, compared 
to an admission rate of 16.3% for all other ED visits (P < 0.001) 
(Table 2). Likewise, hospital LOS was higher in the PH group 
than the remainder of the ED patients admitted at 6.2 days vs 
4.8 days (P < 0.001), and the inpatient mortality was also higher 
for the PH group (4.5% vs 2.6%, P < 0.001). The rate of death 
in the ED was lower in the PH cohort compared to all other 
ED visits, at 0.13% vs 0.17% (P < 0.001). The admission rate 
was over 85% for all years studied, although there was a slight 
decrease in admission rates for PH visits between 2011 and 2015, 
with a peak in 2012 at 88.0% and 86.3% in 2015 (P < 0.001). 
The top 10 ICD-9 primary diagnosis codes for admitted patients 
were hearing loss (389), pneumonia (486), obstructive chronic 
bronchitis (49,121), acute kidney failure (5849), urinary tract 
infection (5990), atrial fibrillation (42,731), acute subendocardial 
myocardial infarction, (41,071), cerebral artery occlusion 
(43,491), other chest pain (78,659), and acute pancreatitis (5770).
Patients with PH had an unadjusted odds ratio mortality of 
1.24 (95% CI, 1.22-1.26) and an adjusted odds ratio (aOR) of 
inpatient mortality of 1.34 (95% CI, 1.31–1.37), compared to all 
other ED visits. Over the five-year period, the inpatient mortality 
remained relatively stable, between 3.8 and 5.1% (P = 0.09) 
(Figure 1). Age had the strongest association with morality, with 
significant increases in mortality for each decile of life, including 
an aOR of 10.6 for those over 80 years old (95% CI, 10.06–
11.22) compared to a reference of ages 18-30 years. Visits by PH 
patients in metropolitan teaching hospitals and those with trauma 
level designation were also associated with increased mortality. 
Female gender and private insurance status were associated with 
decreased aOR for mortality (Table 3).
DISCUSSION
In this nationally representative sample of ED visits, 
presentations by patients with ICD-9-CM and ICD-10-CM 
codes corresponding to PH were relatively common, accounting 
for 0.78% of weighted visits, similar to the results of a recent, 
single-center study.10 PH can arise from numerous etiologies, 
including idiopathic, connective-tissue disease, or drug-related 
causes (Group 1); left heart failure (Group 2); hypoxemic 
respiratory disease (Group 3); chronic thromboembolic disease 
(Group 4); and miscellaneous causes, such as sarcoidosis or 
sickle cell disease (Group 5). An older study using the NEDS 
database evaluated the rate of ED visits for patients with Group 
1 PH,12 a rare condition with a reported prevalence of only 6.6-
25 cases per million per year.17,18 A single-center study analyzed 
the demographics of all five PH groups presenting to the ED,10 
but no study has previously assessed ED visits for patients with 
all five groups in a large, nationwide dataset. Present in almost 
1% of all ED visits, PH is relatively common for a condition that 
has not been previously well described in the ED literature and 
is associated with significantly increased resource utilization and 
inpatient mortality.
In this investigation, most patients with PH were women, 
consistent with prior studies of PH.10,12,19 PH patients were 
significantly older than the remaining ED patient population, 
likely tracking with the development of PH secondary to 
comorbidities, such as left heart failure, hypoxic lung disease, 
and other chronic medical conditions. With improved treatments 
for PH, the life expectancy is increasing,20 and coupled with the 
aging of the population, recognizing PH in the ED will become 
more important. Not only does the management of PH differ 
from other chronic medical conditions,4 but among patients with 
comorbidities such as congestive heart failure, chronic obstructive 
pulmonary disease or interstitial lung disease, PH is associated 
with an increased attributable mortality.21-29 
Patients with PH were significantly more likely to be 
admitted to the hospital than all other patients, at a rate of 
approximately 87%, similar to the previously published report of 
ED patients with Group 1 PH, at 82%.12 Likewise, other studies 
have found an increasing rate of hospitalizations associated with 
PH, including both Group 1 and secondary PH.30,31 A prior study 
demonstrated that the mean hospital LOS for PH increased from 
5.89 days to 6.67 days (p = 0.04) between 2010 and 2013.31 
These values are consistent with our findings for PH admissions 
originating from the ED, at 6.2 days, significantly longer than 
the average LOS for all other admissions from the ED. These 
findings indicate that patients with PH have high acuity in the 
ED. Although emergency physicians traditionally have not 
focused on this patient population,4 they recognize the acuity of 
their ED presentations, as they only discharge about 11%. 
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ED Visit and Hospital 
Characteristics
Sampled 
Unweighted 
ED Visits, n
PH Visits
Weighted, 
n (%) 95% CI
All Other ED Visits
Weighted, 
n (%) 95% CI P-value
Overall 121,503,743 4,233,762 (0.78) 0.75-0.80 541,266,724 (99.22) 99.20-99.25 < 0.001
Age, years < 0.001
18-30 31,633,471 67,213 (1.59) 1.49-1.69 141,853,675 (26.21) 25.96-26.46
31-40 20,130,189 114,276 (2.70) 2.58-2.82 90,156,103 (16.66) 16.54-16.78
41-50 19,095,656 257,371 (6.08) 5.87-6.28 85,328,858 (15.76) 15.65-15.88
51-60 17,817,726 539,174 (12.74) 12.42-13.05 79,640,167 (14.71) 14.60-14.83
61-70 12,909,470 793,668 (18.75) 18.53-18.97 57,234,217 (10.57) 10.48-10.67
71-80 10,092,759 1,034,252 (24.43) 24.18-24.67 44,269,286 (8.18) 8.04-8.32
>80 9,824,472 1,427,806 (33.72) 33.06-34.39 42,784,418 (7.90) 7.71-8.10
Gender < 0.001
Male 51,679,738 1,651,243 (39.00) 38.74-39.27 231,359,767 (42.74) 42.51-42.98
Female 69,824,005 2,582,519 (61.00) 60.73-61.26 309,906,957 (57.26) 57.02-57.49
Primary health insurance < 0.001
Public 60,683,058 3,576,092 (84.47) 83.86-85.07 269,425,287 (49.78) 49.21-50.35
Private 33,302,392 493,085 (11.65) 11.05-12.24 150,158,160 (27.74) 27.18-28.30
Self-pay 20,338,141 86,003 (2.03) 1.88-2.18 89,467,529 (16.53) 15.95-17.11
Other 7,180,152 78,582 (1.86) 1.70-2.01 32,215,748 (5.95) 5.62-6.28
Median household income 
by ZIP code
< 0.001
1 (lowest) 40,894,148 1,235,970 (29.19) 27.81-30.58 180,555,833 (33.36) 32.18-34.53
2 31,486,020 1,064,985 (25.15) 24.02-26.29 141,378,476 (26.12) 25.29-26.95
3 26,541,369 989,032 (23.36) 22.40-24.32 119,089,347 (22.00) 21.21-22.80
4 (highest) 19,926,113 863,663 (20.40) 18.82-21.98 88,385,486 (16.33) 15.31-17.35
unknown 2,656,093 80,112 (1.89) 1.65-2.14 11,857,582 (2.19) 2.06-2.32
Geographic location 0.004
Northeast 22,026,007 733,850 (17.33) 15.62-19.05 103,308,707 (19.09) 17.72-20.45
South 24,564,967 1,027,327 (24.27) 22.04-26.49 124,582,458 (23.02) 21.55-24.49
Midwest 52,412,565 1,756,352 (41.48) 38.91-44.06 215,506,895 (39.82) 38.00-41.63
West 22,500,204 716,233 (16.92) 15.34-18.49 97,868,663 (18.08) 16.98-19.19
Trauma center 0.11
No 51,678,478 1,757,596 (41.51) 39.03-44.00 232,190,969 (42.90) 41.18-44.61
Yes 69,825,265 2,476,166 (58.49) 56.01-60.97 309,075,755 (57.10) 55.39-58.82
Hospital teaching status < 0.001
Metropolitan teaching 54,365,929 2,242,816 (52.97) 50.49-55.46 250,316,054 (46.25) 44.41-48.08
Metropolitan non-
teaching
47,415,858 1,532,608 (36.20) 33.87-38.53 198,375,635 (36.65) 35.05-38.25
Nonmetropolitan 19,721,956 458,338 (10.83) 9.80-11.86 92,575,034 (17.10) 16.21-17.99
Urban location < 0.001
No 6,492,623 76,945 (1.82) 1.53-2.11 30,706,683 (5.67) 5.24-6.10
Yes 115,011,120 4,156,817 (98.18) 97.89-98.47 510,560,041 (94.33) 93.90-94.76
CI, confidence interval; ED, emergency department; PH, pulmonary hypertension.
Table 1. Demographics and hospital characteristics for adult patients with pulmonary hypertension visiting United States emergency 
departments (ED), 2011-2015.
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Accordingly, the inpatient mortality was significantly 
higher for patients with PH than other patients admitted via the 
ED, with a persistent inpatient mortality rate of 4-5% over the 
years studied. These findings are concordant with the previously 
published mortality rate for Group 1 PH patients, at 5.4%.12 A 
population-based analysis of mortality data from the National 
Vital Statistics System for 2001–2010 found that PH as any 
contributing cause of death was 5.5 per 100,000 in 2001 and 6.5 
per 100,000 in 2010.30 
Prior studies of PH have had disparate results regarding 
gender-related differences in mortality, with some finding 
increased mortality in women,30,32 and others, increased 
mortality in men.12,33 In the current study, while PH patients 
were more commonly women, men had a higher risk of 
inpatient mortality, consistent with prior studies based in the 
ED.10,12 The reason for the discrepancy in prior, gender-based 
findings is not clear and merits further investigation. 
Not surprisingly, older age was most strongly associated 
with increased inpatient mortality, with significant increases in 
mortality for each decile of life, including an aOR of 10.6 for 
those over 80 years old. While intuitive, this finding has been 
shown in other studies of Group 1 and secondary PH alike.30,34 
Visits by PH patients to metropolitan teaching hospitals and 
those with trauma level designation were also associated with 
increased mortality, likely reflecting the complexity of patients 
at these institutions. 
Patients with PH often experience a substantial delay 
between the onset of symptoms and diagnosis, with one study 
finding a two-year lag for 21% of patients with Group 1 PH,35 
leading to patients being diagnosed late in their course. Delay 
in diagnosis correlates with decreased survival.36 As this current 
study demonstrates, patients with an existing diagnosis of PH 
were relatively common among ED visits, and with the historical 
under-appreciation of PH,5 more undiagnosed patients may 
also be presenting. The ED is a major point of contact with the 
healthcare system for many patients,37 providing an opportunity 
for the emergency physician to consider the diagnosis and 
make timely referrals. The most common presenting symptom 
for patients with PH is dyspnea,38 a common and nonspecific 
complaint in the ED.39 Given this vague presentation for patients 
with a high-acuity condition, increased awareness among 
emergency physicians is essential to improving timely diagnosis. 
 Outcome PH All Other ED Visits P-value
ED Disposition, n (weighted %)
Discharged 98,270 (10.44) 92,972,703 (77.26) < 0.001
Admitted to hospital 820,892 (86.89) 19778120 (16.28) < 0.001
Death in ED 1,230 (0.13) 209,273 (0.17) < 0.001
Hospital LOS (days), mean (95% CI) 6.21 (6.13-6.28) 4.83 (4.78-4.88) < 0.001
Inpatient mortality, n (weighted %) 36,708 (4.51) 517,463 (2.63) < 0.001
CI, confidence interval; ED, emergency department; LOS, length of hospital stay; PH, pulmonary hypertension
Table 2. Outcomes for United States emergency department (ED) visits for patients with pulmonary hypertension (PH), 2011-2015.
P-value = 0.09
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Figure 1. Change in inpatient mortality rate for pulmonary hypertension (PH) emergency department visits in the United States, 2011-2015. 
P = 0.09 for trend.
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LIMITATIONS
The NEDS database relies on administrative rather than 
clinical data, and this study was not designed to reflect details 
of clinical care in the ED that may have affected mortality or 
admission rates. Second, studies based upon ICD-9-CM and ICD-
10-CM codes are always at risk of classification bias, and this is 
a particular issue with a previously under-reported condition such 
as PH. A review of patients with moderate to severe PH in the VA 
system found that only 17% of these patients had PH documented 
as a diagnosis in their medical records.5 
Other studies have shown that Group 1 PH is recorded in 
public records at a higher prevalence than it is at specialized 
centers.19 It is unknown whether the larger records are 
overestimating the prevalence or whether the specialized 
centers are underestimating. As PH can arise from multiple 
comorbidities known to be associated with increased mortality, 
such as left-sided heart failure and chronic obstructive 
pulmonary disease, these comorbidities may be responsible for 
the increased utilization and mortality seen in the PH cohort. 
However, patients with PH complicating heart failure26 and 
pulmonary disease28 have higher mortality that patients with 
those conditions without PH. 
Changes in the ICD-9-CM and ICD-10-CM coding during 
the study period may also have affected the results. The top 
ICD-9 primary diagnosis codes for admitted patients refer to 
the indication for the outpatient visit in the HCUP database, and 
therefore, do not necessarily reflect the reason the patient was 
admitted. NEDS does not contain patient identifiers. We were 
therefore unable to assess the frequency of return visits, repeat 
admissions, or long-term outcomes.  
CONCLUSION
In this nationally representative sample of US ED visits, 
presentations by patients with ICD-9-CM and ICD-10-CM codes 
corresponding to PH were relatively common, accounting for 
0.78% of visits by adults. Patients with PH were significantly 
more likely to be admitted to the hospital than all other patients 
and had an increased risk of inpatient mortality compared to all 
other ED visits. Older age was most strongly associated with 
increased inpatient mortality. With the aging of the population, 
recognizing PH will become increasingly important for ED 
clinicians. As PH often presents with only vague symptoms, 
emergency physicians should be aware of this common, high-
acuity condition to improve timely diagnosis.
Variables aOR  95% CI P-value
PH disease
No 1 (Reference)
Yes 1.34 1.31-1.37 < 0.001
Age
18-30 1 (Reference)
31-40 1.39 1.34-1.44 < 0.001
41-50 2.39 2.29-2.50 < 0.001
51-60 3.97 3.79-4.16 < 0.001
61-70 5.69 5.41-5.97 < 0.001
71-80 7.38 7.01-7.78 < 0.001
> 80 10.63 10.06-11.22 < 0.001
Gender
Male 1 (Reference)
Female 0.78 0.77-0.78 < 0.001
Primary health insurance
Public 1 (Reference)
Private 0.90 0.88-0.92 < 0.001
Self-pay 1.02 0.98-1.05 0.36
Other 0.96 0.91-1.02 0.15
Geographic location
Northeast 1 (Reference)
South 0.88 0.84-0.92 < 0.001
Midwest 0.92 0.88-0.96 < 0.001
West 1.10 1.05-1.16 < 0.001
Trauma center
No 1 (Reference)
Yes 1.13 1.09-1.18 < 0.001
Hospital teaching status
Metropolitan 
teaching
1 (Reference)
Metropolitan 
non-teaching
0.85 0.82-0.89 < 0.001
Nonmetropolitan 0.89 0.85-0.93 < 0.001
Table 3. Association of pulmonary hypertension (PH) emergency 
department (ED) visits with inpatient mortality in the United States, 
2011-2015.
aOR, adjusted odds ratio; CI, confidence interval; PH, pulmonary 
hypertension.
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